Adaptimmune Therapeutics PLC (ADAP)

0.5912 -0.18 (-23.28%) USD  |  NASDAQ  |  Nov 14, 16:00
0.5793 -0.01 (-2.01%) After-Hours: 06:27
More

Adaptimmune Therapeutics Cash and Short Term Investments (Quarterly): 214.79M for June 30, 2024

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2014. Upgrade now.
Date Value
June 30, 2024 214.79M
March 31, 2024 143.65M
December 31, 2023 146.94M
September 30, 2023 161.73M
June 30, 2023 204.71M
March 31, 2023 165.55M
December 31, 2022 204.60M
September 30, 2022 199.67M
June 30, 2022 258.09M
March 31, 2022 304.22M
December 31, 2021 369.58M
September 30, 2021 240.12M
June 30, 2021 285.37M
March 31, 2021 317.94M
December 31, 2020 368.22M
September 30, 2020 399.91M
June 30, 2020 418.99M
March 31, 2020 196.43M
December 31, 2019 89.54M
Date Value
September 30, 2019 102.86M
June 30, 2019 133.41M
March 31, 2019 168.16M
December 31, 2018 205.13M
September 30, 2018 237.73M
June 30, 2018 129.03M
March 31, 2018 161.83M
December 31, 2017 208.26M
September 30, 2017 231.86M
June 30, 2017 220.02M
March 31, 2017 203.67M
December 31, 2016 181.47M
September 30, 2016 187.50M
June 30, 2016 205.92M
March 31, 2016 226.10M
September 30, 2015 271.91M
December 31, 2014 126.24M
June 30, 2014 51.27M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

89.54M
Minimum
Dec 2019
418.99M
Maximum
Jun 2020
246.84M
Average
214.79M
Median
Jun 2024

Cash and Short Term Investments (Quarterly) Benchmarks

Biodexa Pharmaceuticals PLC 6.394M
Verona Pharma PLC 336.04M
NuCana PLC 14.72M
Autolus Therapeutics PLC 705.94M
Bicycle Therapeutics PLC 890.86M